Kalaris Therapeutics Inc (KLRS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.77
    1.96%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Kalaris Therapeutics Inc Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022
    Period Ending Dec 31, 2023 Dec 31, 2022
    PE Ratio
    		 n/a n/a
    PEG Ratio
    		 n/a n/a
    PS Ratio
    		 n/a n/a
    PB Ratio
    		 n/a n/a
    P/FCF Ratio
    		 n/a n/a
    P/OCF Ratio
    		 n/a n/a
    OCF/S Ratio
    		 n/a n/a
    Debt / Equity Ratio
    		 n/a -0.11
    Quick Ratio
    		 0.85 0.69
    Current Ratio
    		 0.85 0.69
    Asset Turnover
    		 n/a n/a
    Interest Coverage
    		 -19.6 -59.6
    Return on Equity
    		 0.33 0.51
    Return on Assets
    		 -4.41 -3.97
    Return on Invested Capital
    		 22.11 7.82
    Dividend Yield
    		 n/a n/a
    Payout Ratio
    		 n/a n/a
    Gross Profit Margin
    		 n/a n/a
    Net Profit Margin
    		 n/a n/a
    Pretax Profit Margin
    		 n/a n/a
    Operating Profit Margin
    		 n/a n/a
    FCF Margin
    		 n/a n/a
    EBITDA Margin
    		 n/a n/a

    Add to Watchlist